PRME vs REG · rev $3.0M vs P/E 34, $12.93B cap
Prime Medicine, Inc. Common Stock (PRME) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported PRME revenue for 2024-12-31 was $3.0M. Net income was -$195.9M. PRME currently screens at market cap $570.8M.
REG does not have a complete income-statement cache yet.
PRME currently screens at market cap $570.8M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the PRME and REG stock pages for the full models.
Not investment advice.